Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

11.45
Delayed Data
As of Apr 17
 -0.83 / -6.76%
Today’s Change
10.85
Today|||52-Week Range
18.48
-19.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues10.0M0.00256.0K569.0K
 
 
 
 
Cost of Goods Sold--0.0057.0K220.0K
 
 
 
Depreciation And Amortization32.0K56.0K97.0K121.0K
 
 
 
 
 
 
Operating ExpensesGross Income---56.0K102.0K228.0K
 
 
 
 
General Expenses21.6M22.5M35.5M39.9M
 
 
 
 
 
Research And Development14.4M10.3M19.1M5.8M
 
 
 
 
 
Total Operating Expenses21.7M22.5M35.7M40.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.7M-22.5M-35.4M-39.6M
 
 
 
 
 
Extraordinary Charge-2.0M0.000.00--
 
 
Other Expenses0.000.000.0052.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.5M-22.4M-35.3M-39.6M
 
 
 
 
 
Income Taxes0.000.000.00-700.0K
 
 
Net Income-13.5M-22.4M-35.3M-40.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS88.5M91.5M91.8M92.1M
 
 
 
 
 
Shares To Calculate EPS Diluted88.5M91.5M91.8M92.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.24-$0.38-$0.44
 
 
 
 
 
EPS Diluted-$0.15-$0.24-$0.38-$0.44
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account